Design of β-Keto Esters with Antibacterial Activity: Synthesis, In Vitro Evaluation, and Theoretical Assessment of Their Reactivity and Quorum-Sensing Inhibition Capacity

Martinez-Cifuentes, Maximiliano; Soto-Tapia, Emmanuel; Linares-Pipón, Camila; Bradshaw, Ben; Valenzuela-Hormazabal, Paulina; RAMIREZ-SANCHEZ, DAVID MAURICIO; Muñoz-Torres, Patricio; Parra, Claudio

Abstract

This work proposes the design of β-keto esters as antibacterial compounds. The design was based on the structure of the autoinducer of bacterial quorum sensing, N-(3-oxo-hexanoyl)-l-homoserine lactone (3-oxo-C6-HSL). Eight β-keto ester analogues were synthesised with good yields and were spectroscopically characterised, showing that the compounds were only present in their β-keto ester tautomer form. We carried out a computational analysis of the reactivity and ADME (absorption, distribution, metabolism, and excretion) properties of the compounds as well as molecular docking and molecular dynamics calculations with the LasR and LuxS quorum-sensing (QS) proteins, which are involved in bacterial resistance to antibiotics. The results show that all the compounds exhibit reliable ADME properties and that only compound 7 can present electrophile toxicity. The theoretical reactivity study shows that compounds 6 and 8 present a differential local reactivity regarding the rest of the series. Compound 8 presents the most promising potential in terms of its ability to interact with the LasR and LuxS QS proteins efficiently according to its molecular docking and molecular dynamics calculations. An initial in vitro antimicrobial screening was performed against the human pathogenic bacteria Pseudomonas aeruginosa and Staphylococcus aureus as well as the phytopathogenic bacteria Pseudomonas syringae and Agrobacterium tumefaciens. Compounds 6 and 8 exhibit the most promising results in the in vitro antimicrobial screening against the panel of bacteria studied.

Más información

Título según WOS: ID WOS:001099481500001 Not found in local WOS DB
Título según SCOPUS: ID SCOPUS_ID:85175482019 Not found in local SCOPUS DB
Título de la Revista: Pharmaceuticals
Volumen: 16
Fecha de publicación: 2023
DOI:

10.3390/PH16101339

Notas: ISI, SCOPUS